JACOBIO-B (01167) announced that its subsidiary, Beijing Jacobio (an indirect non-wholly owned subsidiary), has received the first payment of RMB 125 million from Oceanpine Capital under the capital increase agreement and equity transfer agreement previously entered into among Beijing Jacobio, Jacobio Ruikang, Oceanpine Capital, and an industrial partner.
The receipt of this initial payment further strengthens the group's cash reserves and will support the advancement of its innovative oncology therapy pipeline.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments